Mohammad RM - Search Results

1

Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model.

Uddin MH, Al-Hallak MN, Khan HY, Aboukameel A, Li Y, Bannoura SF, Dyson G, Kim S, Mzannar Y, Azar I, Odisho T, Mohamed A, Landesman Y, Kim S, Beydoun R, Mohammad RM, Philip PA, Shields AF, Azmi AS. Uddin MH, et al. Among authors: mohammad rm. Clin Transl Med. 2023 Dec;13(12):e1513. doi: 10.1002/ctm2.1513. Clin Transl Med. 2023. PMID: 38131168 Free PMC article.

2

A human B-cell lymphoma line with a de novo multidrug resistance phenotype.

Mohammad RM, Mohamed AN, KuKuruga M, Smith MR, al-Katib A. Mohammad RM, et al. Cancer. 1992 Mar 15;69(6):1468-74. doi: 10.1002/1097-0142(19920315)69:6<1468::aid-cncr2820690626>3.0.co;2-8. Cancer. 1992. PMID: 1540884

3

Conversion of high grade lymphoma tumor cell line to intermediate grade with TPA and bryostatin 1 as determined by polypeptide analysis on 2D gel electrophoresis.

al-Katib A, Mohammad RM, Mohamed AN, Pettit GR, Sensenbrenner LL. al-Katib A, et al. Among authors: mohammad rm. Hematol Oncol. 1990 Mar-Apr;8(2):81-9. doi: 10.1002/hon.2900080203. Hematol Oncol. 1990. PMID: 2344999

4

Establishment and characterization of a new human Burkitt's lymphoma cell line (WSU-BL).

Mohamed AN, Mohammad RM, Koop BF, al-Katib A. Mohamed AN, et al. Among authors: mohammad rm. Cancer. 1989 Sep 1;64(5):1041-8. doi: 10.1002/1097-0142(19890901)64:5<1041::aid-cncr2820640514>3.0.co;2-c. Cancer. 1989. PMID: 2527086

5

Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry.

Mohamed AN, Nakeff A, Mohammad RM, KuKuruga M, al-Katib A. Mohamed AN, et al. Among authors: mohammad rm. Oncogene. 1988 Oct;3(4):429-35. Oncogene. 1988. PMID: 3152600

6

A unique EBV-negative low-grade lymphoma line (WSU-FSCCL) exhibiting both t(14;18) and t(8;11).

Mohammad RM, Mohamed AN, Smith MR, Jawadi NS, al-Katib A. Mohammad RM, et al. Cancer Genet Cytogenet. 1993 Oct 1;70(1):62-7. doi: 10.1016/0165-4608(93)90132-6. Cancer Genet Cytogenet. 1993. PMID: 8221615

7

Propagation of Waldenström's macroglobulinemia cells in vitro and in severe combined immune deficient mice: utility as a preclinical drug screening model.

al-Katib A, Mohammad R, Hamdan M, Mohamed AN, Dan M, Smith MR. al-Katib A, et al. Blood. 1993 Jun 1;81(11):3034-42. Blood. 1993. PMID: 8499639 Free article.

8

Bryostatin 1 (bryo1)-induced monocytic differentiation in THP-1 human leukemia cells is associated with enhanced c-fyn tyrosine kinase and M-CSF receptors.

Li Y, Mohammad RM, al-Katib A, Varterasian ML, Chen B. Li Y, et al. Among authors: mohammad rm. Leuk Res. 1997 May;21(5):391-7. doi: 10.1016/s0145-2126(96)00078-1. Leuk Res. 1997. PMID: 9225065

9

Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agents.

Mohammad RM, Dugan MC, Mohamed AN, Almatchy VP, Flake TM, Dergham ST, Shields AF, Al-Katib AA, Vaitkevicius VK, Sarkar FH. Mohammad RM, et al. Pancreas. 1998 Jan;16(1):19-25. doi: 10.1097/00006676-199801000-00004. Pancreas. 1998. PMID: 9436858

10

Bryostatin 1 down-regulates mdr1 and potentiates vincristine cytotoxicity in diffuse large cell lymphoma xenografts.

Al-Katib AM, Smith MR, Kamanda WS, Pettit GR, Hamdan M, Mohamed AN, Chelladurai B, Mohammad RM. Al-Katib AM, et al. Among authors: mohammad rm. Clin Cancer Res. 1998 May;4(5):1305-14. Clin Cancer Res. 1998. PMID: 9607591

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

214 results

Search Page